Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials

Dario Pasalic, Gwendolyn J. McGinnis, Clifton D. Fuller, Aaron J. Grossberg, Vivek Verma, W. Ian P. Mainwaring, Austin B. Miller, Timothy A. Lin, Amit Jethanandani, Andres F. Espinoza, Markus Diefenhardt, Prajnan Das, Vivek Subbiah, Ishwaria M. Subbiah, Reshma Jagsi, Adam S. Garden, Emmanouil Fokas, Claus Rödel, Charles R. Thomas, Bruce D. Minsky, Ethan B. Ludmir